10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevalence of and Trends in Dyslipidemia and Blood Pressure Among US Children and Adolescents, 1999–2012

      research-article
      , MD, MPH, , MD, , MSPH, , PhD, RN, , PhD, , PhD
      JAMA pediatrics

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          IMPORTANCE

          Recent national data suggest there were improvements in serum lipid concentrations among US children and adolescents between 1988 and 2010 but an increase in or stable blood pressure (BP) during a similar period.

          OBJECTIVE

          To describe the prevalence of and trends in dyslipidemia and adverse BP among US children and adolescents.

          DESIGN

          The National Health and Nutrition Examination Survey, a cross-sectional survey.

          SETTING

          Noninstitutionalized US population.

          PARTICIPANTS

          Children and adolescents aged 8 to 17 years with measured lipid concentrations (n = 1482) and BP (n = 1665).

          MAIN OUTCOMES AND MEASURES

          Adverse concentrations of total cholesterol (TC) (≥200 mg/dL), high-density lipoprotein cholesterol (HDL-C) (<40 mg/dL), and non-HDL-C (≥145 mg/dL) (to convert TC, HDL-C, and non-HDL-C to millimoles per liter, multiply by 0.0259) and high or borderline BP were examined. Definitions of BP were informed by the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents by the National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. Analyses of linear trends in dyslipidemias and BP were conducted overall and separately by sex across 7 periods (1999–2000, 2001–2002, 2003–2004, 2005–2006, 2007–2008, 2009–2010, and 2011–2012).

          RESULTS

          In 2011–2012, 20.2% (95% CI, 16.3–24.6) of youths had an adverse concentration of TC, HDL-C, or non-HDL-C and 11.0% (95% CI, 8.8–13.4) had either high or borderline BP. The prevalences of adverse concentrations decreased between 1999–2000 and 2011–2012 for TC (10.6% [95% CI, 8.3–13.2] vs 7.8% [95% CI, 5.7–10.4]; P = .006), HDL-C (17.9% [95% CI, 15.0–21.0] vs 12.8% [95% CI, 9.8–16.2]; P = .003), and non-HDL-C (13.6% [95% CI, 11.3–16.2] vs 8.4% [95% CI, 5.9–11.5]; P < .001). There was a decrease in high BP between 1999–2000 (3.0% [95% CI, 2.0–4.3]) and 2011–2012 (1.6% [95% CI, 1.0–2.4]) ( P = .003). There was no change from 1999–2000 to 2011–2012 in borderline high BP (7.6% [95% CI, 5.8–9.8] vs 9.4% [95% CI, 7.2–11.9]; P = .90) or either high or borderline high BP (10.6% [8.4–13.1] vs 11.0% [95% CI, 8.8–13.4]; P = .26).

          CONCLUSIONS AND RELEVANCE

          In 2011–2012, approximately 1 in 5 children and adolescents aged 8 to 17 years had an adverse lipid concentration of TC, HDL-C, or non-HDL-C and slightly more than 1 in 10 had either borderline high or high BP. The prevalence of dyslipidemia modestly decreased between 1999–2000 and 2011–2012, but either high or borderline high BP remained stable. The reasons for these trends require further study.

          Related collections

          Author and article information

          Journal
          101589544
          40868
          JAMA Pediatr
          JAMA Pediatr
          JAMA pediatrics
          2168-6203
          2168-6211
          26 January 2016
          March 2015
          12 August 2020
          : 169
          : 3
          : 272-279
          Affiliations
          US Public Health Service, Rockville, Maryland (Kit); Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland (Kit, Carroll, Ostchega, Ogden); Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia (Kuklina); Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia (Freedman)
          Author notes
          Corresponding Author: Brian K. Kit, MD, MPH, Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Rd, Room 4419, Hyattsville, MD 20782 ( igd0@ 123456cdc.gov )
          Article
          PMC7423159 PMC7423159 7423159 hhspa753886
          10.1001/jamapediatrics.2014.3216
          7423159
          25599372
          11fc86bb-637e-46e8-a920-a47fd9c46bea
          History
          Categories
          Article

          Comments

          Comment on this article